Explore current and completed reviews, reforms and regulatory changes administered by the Office of Drug Control.
Medicinal cannabis
- PageUnderstand the reforms to medicinal cannabis licences and permits that commenced on 24 December 2021.
- PageFind information about medicinal cannabis cost recovery and current and previous Cost Recovery Implementation Statements (CRIS).
- PageRead about the review of the medicinal cannabis regulatory framework and the resulting approach to managing regulatory risks.
Other controlled substances
- PageLearn about changes to personal and commercial kava imports and the monitoring and evaluation of the kava pilot.